Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: A Report from the Children's Cancer Group

Journal of Clinical Oncology

Volumn 23, Issue 30, 2005, Pages 7621-7631

  Geyer, J Russell ^a   Sposto, Richard ^b   Jennings, Mark ^b   Boyett, James M ^b   Axtell, Richard A ^b   Breiger, David ^b   Broxson, Emmett ^b   Donahue, Bernadine ^b   Finlay, Jonathan L ^b   Goldwein, Joel W ^b   Heier, Linda A ^b   Johnson, Dennis ^b   Mazewski, Claire ^b   Miller, Douglas C ^b   Packer, Roger ^b   Puccetti, Diane ^b   Radcliffe, Jerilynn ^b   Tao, May Lin ^b   Shiminski Maher, Tania ^b  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MESNA; VINCRISTINE; ANTINEOPLASTIC AGENT;

ARTICLE; BLOOD TOXICITY; BRAIN TUMOR; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG DOSE REGIMEN; ELECTROLYTE DISTURBANCE; EPENDYMOMA; FEMALE; FEVER; HUMAN; INFANT; INFECTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; NEUROECTODERM TUMOR; NEUROTOXICITY; OTOTOXICITY; PHASE 3 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHABDOID TUMOR; TREATMENT FAILURE; TREATMENT RESPONSE; GLIOMA; MULTIMODALITY CANCER THERAPY; NEOPLASM; NEWBORN; SURVIVAL RATE; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHILD, PRESCHOOL; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; EPENDYMOMA; ETOPOSIDE; FEMALE; GLIOMA; HUMANS; IFOSFAMIDE; INFANT; INFANT, NEWBORN; MALE; MEDULLOBLASTOMA; NEOPLASMS, GERM CELL AND EMBRYONAL; NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

EID: 32944482676     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.09.095     Document Type: Article

References (28)

1. Smith MA, Gurney JG, Linet M, et al (eds): Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995, National Cancer Institute, Bethesda, MD, 1999
2. Zeltzer PM, Boyett JM, Finlay JL, et al: Metastasis stage, adjuvant treatment and residual tumor are prognostic factors for medulloblastoma in children: Conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 17:832-845, 1999
3. Cohen BH, Zeltzer PM, Boyett JM, et al: Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: A Children's Cancer Group randomized trial. J Clin Oncol 13:1687-1696, 1995
4. Cohen BH, Packer RJ, Siegel KR, et al: Brain tumors in children under 2 years: Treatment, survival, and long-term prognosis. Pediatr Neurosurg 19:171-179, 1993
5. Di Rocco C, Iannelli A, Ceddia A: Intracranial tumors of the first year of life: A cooperative survey of the 1986-1987 Education Committee of the ISPN. Childs Nerv Syst 7:150-153, 1991
6. Di Rocco C, Iannelli A, Papacci F, et al: Prognosis of medulloblastoma in infants. Childs Nerv Syst 13:388-396, 1997
7. Ilveskoski I, Pihko H, Sankila R, et al: Improving outcome of malignant brain tumours in very young children: A population-based study in Finland during 1975-93. Acta Paediatr 86:724-729, 1997
8. Massimino M, Gandola L, Cefalo G, et al: Management of medulloblastoma and ependymoma in infants: A single-institution long-term retrospective report. Childs Nerv Syst 16:15-20, 2000
9. Kiltie A, Lashford L, Gattamaneni H: Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old. Med Pediatr Oncol 28:348-354, 1997
10. Walter A, Mulhern RK, Gajjar A, et al: Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital. J Clin Oncol 17: 3720-3728, 1999
11. Kellie SJ: Chemotherapy of central nervous system tumours in infants. Childs Nerv Syst 15:592-612, 1999
12. Duffner PK, Kun LE, Burger PC, et al: Postoperative chemotherapy and delayed radiation in infants and very young children with choroid plexus carcinomas. Pediatr Neurosurg 22:189-196, 1995
13. Geyer J, Zeltzer PM, Boyett JM, et al: Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: A report from the Children's Cancer Group. J Clin Oncol 12:1607-1615, 1994
14. Duffner PK, Krischer JP, Burger PC, et al: Treatment of infants with malignant gliomas: The Pediatric Oncology Group experience. J Neurooncol 28:245-256, 1996
15. Geyer J, Finlay JL, Boyett JM, et al: Survival of infants with malignant astrocytomas: A report from the Children's Cancer Group. Cancer 75:1045-1050, 1995
16. Duffner P, Krischer JP, Sanford RA, et al: Prognostic factors in infants and very young children with intracranial ependymomas. Pediatr Neurosurg 28:215-222, 1998
17. Duffner P, Horowitz ME, Krischer JP, et al: Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328:1725-1731, 1993
18. Albright A, Wisoff JH, Zeltzer PM, et al: Effects of medulloblastoma resections on outcome in children: A report from the Children's Cancer Group. Neurosurgery 38:265-271, 1996
19. Geyer R, Berger M, Allen J, et al: Intensive chemotherapy pilot for infants with malignant brain tumors. Proc Am Soc Clin Oncol 12:417, 1993 (abstr 1431)
20. International Society of Pediatric Oncology: SIOP XXIII Meeting. Med Pediatr Oncol 19:406, 1991
21. Cox D, Oakes D: Analysis of Survival Data. London, United Kingdom, Chapman and Hall, 1984
22. Sposto R, Sather H: Determining the duration of comparative clinical trials while allowing for cure. J Chronic Dis 38:683-690, 1985
23. Hilden J, Watterson J, Longee DC, et al: Central nervous system atypical teratoid tumor/ rhabdoid tumor: Response to intensive therapy and review of the literature. J Neurooncol 40: 265-275, 1998
24. Bhattacharjee M, Hicks J, Langford L, et al: Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood. Ultrastruct Pathol 21:369-378, 1997
25. Siegel J, Rorke LB, Packer RJ, et al: Monosomy 22 in rhabdoid or atypical tumors of the brain. J Neurosurg 73:710-714, 1990
26. Siegel JA, Zhou JY, Rorke LB, et al: Germline and acquired mutations of INU in atypical teratoid and rhabdoid tumors. Cancer Res 59:74-79, 1999
27. Grotzer M, Hogarty MD, Janss AJ, et al: MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma. Clin Cancer Res 7:2425-2433, 2001
28. Grotzer M, Janss AJ, Fung K, et al:, TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. J Clin Oncol 18:1027-1035, 2000